【24h】

Use of cytarabine and idarubicin in a newly diagnosed AML patient with a severe wound.

机译:阿糖胞苷和伊达比星在新诊断为严重伤口的AML患者中的使用。

获取原文
获取原文并翻译 | 示例
           

摘要

Acute myeloid leukemia (AML) is malignant tumor of haemopoietic precursor cells of non-lymphoid lineage. AML can atypically present with non-spesific cutaneous lesions or wounds. There are rare acute leukemia cases which present with genital ulcerations or pyoderma gangrenosum in the literature. The effect of acute leukemia on wound healing is not known, but it is thought that cytopenias and chemotherapy can impair wound healing in patients with leukemia. The effects of chemotherapeutic agents on wound healing are arguable. Here we present wound care strategies and simultaneously applied chemotherapy in an AML patient.
机译:急性髓性白血病(AML)是非淋巴谱系的造血前体细胞的恶性肿瘤。 AML可非典型地出现非特异性皮肤病变或伤口。在文献中很少有急性白血病病例出现生殖器溃疡或坏疽性脓皮病。急性白血病对伤口愈合的影响尚不清楚,但据认为血细胞减少和化学疗法会损害白血病患者的伤口愈合。化疗药物对伤口愈合的作用是有争议的。在这里,我们介绍了伤口护理策略,并在AML患者中同时应用了化疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号